$5.12
-0.46-8.32%
Last update: May 21, 12:15 AM
15 minutes delayed
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Innovent Biologics in recent months.
Browse guidance and forecast on all stocks.